SIMBA in Irritable Bowel Syndrome (IBS) | MicrobiomeTrials← Back to trialsNCT07882953
SIMBA in Irritable Bowel Syndrome (IBS)
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2026-11Est. Completion: 2027-12
Enrollment target: 180 participants Locations- University of Calgary, Foothills Campus, Calgary, Alberta, Canada
Other microbiome trials you might be interested in
ConstipationProbioticProbiotic Intervention
Constipation is a prevalent gastrointestinal condition. Beyond simple lifestyle measures (e.g. increasing fibre intake, …
London, United KingdomCompleted Jul 20, 2026
Irritable Bowel Syndrome (IBS)
Randomized, single-blind, sham-controlled crossover study evaluating the efficacy and safety of transcutaneous auricular…
Multiple LocationsEst. completion Dec 31, 2028
Recruiting
IBSUlcerative Colitis, ActiveUlcerative Colitis, Remission (3a: With IBS Symptoms, 3b: Without IBS Symptoms)Healthy ControlsCrohn's Disease, ActiveCrohn's Disease, Remission (6a: With IBS Symptoms, 6b: Without IBS Symptoms)
Aim:
More insight in pathogenesis of IBS and IBD. Samples are collected in context of an European research project.
Leuven, BelgiumEst. completion Jan 2099